Parkinson’s
Phytopharm suffers Parkinson’s loss
February 20, 2013Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane
Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …
Takeda to buy Envoy Therapeutics
November 7, 2012Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda
Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …
Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops
July 30, 2012Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss
A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Roche signs Alzheimer’s deal with reMYND
September 7, 2010Research and Development Alzheimer's, Parkinson's, Roche, reMYND
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Pharma pools trial data for brain disorder research
June 14, 2010Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships
Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …
Latest content
FibroFind appoints Lee Borthwick as CEO
